Chul Jang Kim
- Urology top 10%
- Urological Disorders and Treatments 5
-
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 3
-
- Bladder and Urothelial Cancer Treatments 7
- Urinary and Genital Oncology Studies 4
-
- Pediatric Urology and Nephrology Studies 6
-
- Ureteral procedures and complications 5
-
- Prostate Cancer Diagnosis and Treatment 3
- Co-authors
- Yusaku OkadaHirokazu InoueYukihiro TambeRyoji KushimaHiroyuki SugiharaNaohisa YoshiokaTakahiro KawakamiTatsuhiro Yoshiki
- Cited by
- Cancer ResearchUrologyOncology
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Chul Jang Kim
25 papers receiving 357 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 97
- Urology 36
- Oncology 91
- Molecular Biology 213
- Cardiology and Cardiovascular Medicine 54
Countries citing papers authored by Chul Jang Kim
This map shows the geographic impact of Chul Jang Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul Jang Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul Jang Kim more than expected).
Fields of papers citing papers by Chul Jang Kim
This network shows the impact of papers produced by Chul Jang Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul Jang Kim. The network helps show where Chul Jang Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chul Jang Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2021 | 3 | |
| 3 | 2021 | 3 | |
| 4 | 2018 | 2 | |
| 5 | 2017 | 9 | |
| 6 | 2016 | 11 | |
| 7 | 2013 | 8 | |
| 8 | 2011 | 4 | |
| 9 | 2009 | 28 | |
| 10 | 2009 | 2 | |
| 11 | 2007 | 4 | |
| 12 | 2006 | 6 | |
| 13 | [Small cell carcinoma of the prostate: a report of three patients and a prognostic analysis of cases reported in Japan]. | 2006 | 3 |
| 14 | 2005 | 80 | |
| 15 | 2005 | 22 | |
| 16 | 2004 | 81 | |
| 17 | 2004 | 23 | |
| 18 | 2004 | 4 | |
| 19 | 2003 | 25 | |
| 20 | [Intractable duodenocutaneous fistula after nephrectomy for stone pyonephrosis: report of a case]. | 2003 | 2 |
About Chul Jang Kim
Chul Jang Kim is a scholar working on Urology, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health, having authored 28 papers that have together received 364 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Pediatric Urology and Nephrology Studies (6 papers), Urological Disorders and Treatments (5 papers), Ureteral procedures and complications (5 papers), Urinary and Genital Oncology Studies (4 papers), Peptidase Inhibition and Analysis (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (97 citations), Urology (36 citations) and Oncology (91 citations). Chul Jang Kim has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Yusaku Okada, Hirokazu Inoue, Yukihiro Tambe, Ryoji Kushima, Hiroyuki Sugihara, Naohisa Yoshioka, Takahiro Kawakami, Tatsuhiro Yoshiki, Yoshihiko Wakabayashi and Ken‐ichi Mukaisho. Their work appears in journals such as Oncogene, International Journal of Cancer and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.